Search results for: 'AMI Infrastructure Developments across Asia'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprises insights across new developments for antibody-drug conjugates, T-cell engagers, cell and gene therapies, precision immunology and cancer care.The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life science...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therap...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers insights across biomanufacturing, targeted drug delivery, imaging, precision medicine and biologics innovations.The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and ...

Carbon nanotubes (CNTs) are emerging as a cornerstone material for next-generation industries, enabling breakthroughs in electric vehicles, aerospace, energy storage, and flexible electronics through their unique combination of lightweight structure, exceptional electrical conductivity, and superior mechanical and thermal performance. Beyond enhanc...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...

This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...